Anti-Glc(alpha 1,4)Glc(alpha) IgM antibodies for predict the development of relapsing-remitting multiple sclerosis after the first neurological event

Freedman, MS; Sindic, Christian; Dotan, N.; Schwarz, Maik; Weishaus, O; Dukler, A.; Miller, A

doi:10.1191/1352458505ms1126oa

Anti-Glc(alpha 1,4)Glc(alpha) IgM antibodies for predict the development of relapsing-remitting multiple sclerosis after the first neurological event

Freedman, MS

;

Sindic, Christian

;

Dotan, N.

;

Schwarz, Maik

;

Miller, A

;et.al.

(2005) 21st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis/10th Annual Meeting of Rehabilitation in MS — Location: Thessaloniki (Greece) (28.September.2005)

Files

No attached file found for this publication.

Details

Authors

Freedman, MS
Author
Sindic, ChristianUCLouvain
Author
Dotan, N.
Author
Schwarz, MaikUCLouvain
Author
Miller, A
Author

Affiliations

Citations

APA
Chicago
FWB

Freedman, M., Sindic, C., Dotan, N., Schwarz, M., Weishaus, O., Dukler, A., & Miller, A. (2005). Anti-Glc(alpha 1,4)Glc(alpha) IgM antibodies for predict the development of relapsing-remitting multiple sclerosis after the first neurological event. Multiple Sclerosis Journal, 11, S180-S181. https://doi.org/10.1191/1352458505ms1126oa (Original work published 2005)